chr19-10176959-A-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001130823.3(DNMT1):c.569+333T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.512 in 151,916 control chromosomes in the GnomAD database, including 20,156 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.51 ( 20156 hom., cov: 31)
Consequence
DNMT1
NM_001130823.3 intron
NM_001130823.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.820
Publications
8 publications found
Genes affected
DNMT1 (HGNC:2976): (DNA methyltransferase 1) This gene encodes an enzyme that transfers methyl groups to cytosine nucleotides of genomic DNA. This protein is the major enzyme responsible for maintaining methylation patterns following DNA replication and shows a preference for hemi-methylated DNA. Methylation of DNA is an important component of mammalian epigenetic gene regulation. Aberrant methylation patterns are found in human tumors and associated with developmental abnormalities. Variation in this gene has been associated with cerebellar ataxia, deafness, and narcolepsy, and neuropathy, hereditary sensory, type IE. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNMT1 Gene-Disease associations (from GenCC):
- autosomal dominant cerebellar ataxia, deafness and narcolepsyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)
- hereditary sensory neuropathy-deafness-dementia syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.656 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNMT1 | NM_001130823.3 | c.569+333T>A | intron_variant | Intron 6 of 40 | ENST00000359526.9 | NP_001124295.1 | ||
| DNMT1 | NM_001318730.2 | c.521+333T>A | intron_variant | Intron 5 of 39 | NP_001305659.1 | |||
| DNMT1 | NM_001379.4 | c.521+333T>A | intron_variant | Intron 5 of 39 | NP_001370.1 | |||
| DNMT1 | NM_001318731.2 | c.206+333T>A | intron_variant | Intron 6 of 40 | NP_001305660.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.512 AC: 77727AN: 151798Hom.: 20123 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
77727
AN:
151798
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.512 AC: 77824AN: 151916Hom.: 20156 Cov.: 31 AF XY: 0.514 AC XY: 38116AN XY: 74214 show subpopulations
GnomAD4 genome
AF:
AC:
77824
AN:
151916
Hom.:
Cov.:
31
AF XY:
AC XY:
38116
AN XY:
74214
show subpopulations
African (AFR)
AF:
AC:
21349
AN:
41458
American (AMR)
AF:
AC:
7511
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
AC:
1928
AN:
3466
East Asian (EAS)
AF:
AC:
3488
AN:
5166
South Asian (SAS)
AF:
AC:
2633
AN:
4814
European-Finnish (FIN)
AF:
AC:
5424
AN:
10530
Middle Eastern (MID)
AF:
AC:
158
AN:
294
European-Non Finnish (NFE)
AF:
AC:
33787
AN:
67948
Other (OTH)
AF:
AC:
1038
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1916
3832
5748
7664
9580
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
706
1412
2118
2824
3530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2107
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.